Vimarsana
Biggest News Aggregation in the World

Page 35 - Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Today - Breaking & Trending Today

The Clinical Laboratories Market in Vietnam is expected to generate ~$560 Mn owing to rise in diseases, growth in Health-Tech startups and rise of new technologies: Ken Research - Vimarsana News

The Clinical Laboratories Market in Vietnam is expected to generate ~$560 Mn owing to rise in diseases, growth in Health-Tech startups and rise of new technologies: Ken Research

GURUGRAM, India, Feb. 1, 2023 /PRNewswire/ -- Vietnam Clinical Laboratories Market is at growing stage and has moderately fragmented market with about 10-12 organized lab chains and 7-8 Private

'Smart' Skin Patch the Future of Early Alzheimer's Diagnosis? - Vimarsana News

'Smart' Skin Patch the Future of Early Alzheimer's Diagnosis?

A new skin patch that incorporates microneedles can detect the proinflammatory cytokine IL-6 in the lab, suggesting it may have the potential to diagnose preclinical Alzheimer's and other diseases.

Sudden Cardiac Arrest Risk During Sports Low in Older Adults - Vimarsana News

Sudden Cardiac Arrest Risk During Sports Low in Older Adults

US adults ages 65 and older who engage in regular physical activity are at low risk of sports-related sudden cardiac arrest.

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Apple health VP in India next month, to share how healthtech is empowering millions - Vimarsana News

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Apple health VP in India next month, to share how healthtech is empowering millions

Desai, who recently served as Vice Chair of Strategy and Innovation in the Department of Medicine at Stanford Medicine in the US, will participate in a fireside chat with Dr Sangita Reddy, Joint Managing Director of Apollo Hospitals, at the flagshi‘ 'BioAsia 2023' event in Hyderabad on February 25.BioA

Sinopharm's mRNA Omicron vaccine gets green light for trials - Vimarsana News

Sinopharm's mRNA Omicron vaccine gets green light for trials

China National Biotec Group, a subsidiary of China National Pharmaceutical Group Co Ltd (Sinopharm), announced on Friday that its biotech unit in Shanghai has received regulatory approval for clinical trials of China's first mRNA COVID-19 vaccine targeting the Omicron strains.